DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
In: BMC Cancer, Jg. 13 (2013-09-01), Heft 1, S. 1-9
Online
academicJournal
Zugriff:
Background: The DEK protein is related to chromatin reconstruction and gene transcription, and plays an important role in cell apoptosis. High expression levels of the human DEK gene have been correlated with numerous human malignancies. This study explores the roles of DEK in tumor progression and as a prognostic determinant of colorectal cancer. Methods: Colorectal cancer specimens from 109 patients with strict follow-up, and colorectal adenomas from 52 patients were selected for analysis of DEK protein by immunohistochemistry. The correlations between DEK over expression and the clinicopathological features of colorectal cancers were evaluated by Chi-square test and Fisher's exact tests. The survival rates were calculated by the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was also analyzed by the Cox proportional hazard models. Results: DEK protein showed a nuclear immunohistochemical staining pattern in colorectal cancers. The strongly positive rate of DEK protein was 48.62% (53/109) in colorectal cancers, which was significantly higher than that in either adjacent normal colon mucosa (9.17%, 10/109) or colorectal adenomas (13.46%, 7/52). DEK over expression in colorectal cancers was positively correlated with tumor size, grade, lymph node metastasis, serosal invasion, late stage, and disease-free survival- and 5-year survival rates. Further analysis showed that patients with late stage colorectal cancer and high DEK expression had worse survival rates than those with low DEK expression. Moreover, multivariate analysis showed high DEK expression, serosal invasion, and late stage are significant independent risk factors for mortality in colorectal cancer. Conclusions: DEK plays an important role in the progression of colorectal cancers and it is an independent poor prognostic factor of colorectal cancers. [ABSTRACT FROM AUTHOR]
Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
|
---|---|
Autor/in / Beteiligte Person: | Lin, Lijuan ; Piao, Junjie ; Gao, Wenbin ; Piao, Yingshi ; Jin, Guang ; Ma, Yue ; Li, Jinzi ; Lin, Zhenhua |
Link: | |
Zeitschrift: | BMC Cancer, Jg. 13 (2013-09-01), Heft 1, S. 1-9 |
Veröffentlichung: | 2013 |
Medientyp: | academicJournal |
ISSN: | 1471-2407 (print) |
DOI: | 10.1186/1471-2407-13-366 |
Schlagwort: |
|
Sonstiges: |
|